Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / SNY - Amicus Therapeutics: Inflection Point Coming In 2021

SNY - Amicus Therapeutics: Inflection Point Coming In 2021

Sanofi
  • Amicus is making progress on all fronts and the progress is not fully reflected in the company's valuation.
  • Galafold is on track to generate $500 million in global sales by 2023.
  • The phase 3 trial of AT-GAA in Pompe disease patients is on track to report results in 1H 2021 and is well-positioned to become the standard of care.
  • The gene therapy portfolio is yet to get any market recognition and this should change in the next 18-24 months.
  • Amicus is well funded to execute on all fronts.

For further details see:

Amicus Therapeutics: Inflection Point Coming In 2021
Stock Information
Company Name: Sanofi
Stock Symbol: SNY
Market: NASDAQ
Website: sanofi.com
Menu
SNY SNY Quote SNY Short SNY News SNY Articles SNY Message Board
Get SNY Alerts

News, Short Squeeze, Breakout and More Instantly...